Ovarian Cancer’s Hidden Threat? It’s in the Fluid, Not the TumorResearch reveals how ascites in ovarian cancer disrupts immunity, hindering tumor defense but offers potential treatment solutions.
Corcept’s New Cancer Pill Boosts Survival for Drug-Resistant PatientsCorcept's Relacorilant shows promise in treating platinum-resistant ovarian cancer, extending survival by 4.5 months in trials.
Ovarian Cancer: Early Detection and Prevention StrategiesOvarian cancer, the deadliest gynecological cancer, is often diagnosed late; early detection can significantly improve survival rates.
Ovarian Cancer’s Hidden Threat? It’s in the Fluid, Not the Tumor Research reveals how ascites in ovarian cancer disrupts immunity, hindering tumor defense but offers potential treatment solutions.
Corcept’s New Cancer Pill Boosts Survival for Drug-Resistant Patients Corcept's Relacorilant shows promise in treating platinum-resistant ovarian cancer, extending survival by 4.5 months in trials.
Ovarian Cancer: Early Detection and Prevention Strategies Ovarian cancer, the deadliest gynecological cancer, is often diagnosed late; early detection can significantly improve survival rates.
Hot Topics